RESUMO
OBJECTIVE:To observe therapeutic efficacy of candesartan combined with Sulodexide soft capsules in the treatment of persistent proteinuria of diabetic nephropathy. METHODS:180 patients with persistent proteinuria of diabetic ne-phropathy were randomly divided into control group and trial group,with 90 cases in each group. Control group was given can-desartan,8 mg/time,once a day;trial group was additionally given Sulodexide soft capsules on the basis of control group,250 LSU/time,twice a day. The indexes levels of both groups were compared before and after treatment,including systolic blood pressure(SBP),diastolic blood pressure(DBP),serum creatinine(Scr),blood urea nitrogen(BUN),urinary albumin excre-tion rate (UAER),24 hour urinary albumin (24hU-Alb) and urinary 2-microglobulin (β2-MG),α1 microglobulin (α1-MG), urine N-acetyl-β-D glucoside enzyme(NAG)and serum cystatin C(Cys-C). RESULTS:After treatment,there was no statisti-cal significance in the levels of SBP,DBP,Scr,BUN and UAER between 2 groups(P>0.05);24hU-Alb level of observation group was significantly betRter than that of control group,with statistical significance (P<0.05);after treatment,β2-MG,α1-MG,NAG and Cys-C of 2 groups were all improved significantly,and the trial group was more significant then the control group,with statistical significance (P<0.05). CONCLUSIONS:Candesartan combined with Sulodexide soft capsules in the treatment of persistent proteinuria of diabetic nephropathy can effectively improve renal function and reduce urinary microalbu-min.
RESUMO
0. 05). The mean survival time in Iodine-125 stent group was 10. 5 months prominently longer than those in group A 4. 4 months (P